Welcome to our dedicated page for Klaviyo SEC filings (Ticker: KVYO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Klaviyo, Inc. (NYSE: KVYO) files a range of reports and disclosures with the U.S. Securities and Exchange Commission that shed light on its business, governance, and financial performance. This page aggregates those SEC filings so investors can review how the company describes its B2C CRM platform, subscription-based SaaS model, AI capabilities, and key operating metrics in official documents.
Among the most informative filings for Klaviyo are its annual reports on Form 10-K and quarterly reports on Form 10-Q, which provide detailed discussions of revenue, expenses, customer trends, and risks, as well as explanations of non-GAAP measures such as non-GAAP gross profit, non-GAAP operating income, and free cash flow. These reports also define operational metrics like customers, customers generating over specified annual recurring revenue thresholds, and dollar-based net revenue retention rate, and explain how management uses them to evaluate growth.
Current reports on Form 8-K give more timely insight into specific events. In 2025, Klaviyo used 8-K filings to announce quarterly results, share Black Friday–Cyber Monday data, post an investor day presentation, disclose an underwriting agreement for a secondary offering by selling stockholders, and describe leadership and governance changes, including the appointment of a co-Chief Executive Officer and amendments to its bylaws to allow for up to two Chief Executive Officers.
Investors can also review exhibits attached to these filings, such as employment agreements, compensation arrangements, equity award intention letters, and underwriting agreements, to better understand executive incentives, severance terms, and capital markets activity. Insider transaction reports on Form 4, when filed, provide additional visibility into equity ownership changes by directors and officers. With AI-powered summaries and search, this filings page helps users interpret lengthy documents, follow how Klaviyo’s disclosures evolve over time, and quickly locate information on topics such as executive compensation, stock-based awards, performance metrics, and material agreements.
Klaviyo, Inc. (KVYO) Form 4 reports that Summit Partners-affiliated entities effected transactions on 08/25/2025. The filing shows 975,000 shares acquired as Series B common stock (convertible into Series A) and a contemporaneous sale of 975,000 shares of Series A common stock at $30.01 per share. The reporting group collectively beneficially owns 22,852,778 shares (on an indicated Series A-equivalent basis) across multiple Summit funds. The filing is executed by Adam Hennessey as attorney-in-fact for the Summit reporting persons and includes explanatory footnotes describing the ownership and control structure within the Summit Partners organization.
Klaviyo, Inc. (KVYO) Form 144 notice reports a proposed sale of 2,333,334 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $73,663,354.38. The shares represent approximately 2.0% of the 116,897,730 shares outstanding and are scheduled for sale on 08/26/2025 on the NYSE. The securities were acquired on 05/14/2025 through previously exercised stock options and were paid for in cash. The filing also discloses a prior sale by Andrew Bialecki of 100,000 shares on 06/17/2025 for $3,441,330.00. The filer affirms no undisclosed material adverse information and includes broker contact details for the planned sale.
Summit Partners entities reported the disposition of 500,000 shares of Klaviyo, Inc. Series A common stock on 08/21/2025; the sale is reported as a distribution to facilitate bona fide charitable gifts and was effected at a $0 price in the Form 4 filing. Following the reported transaction, the reporting persons show 0 shares beneficially owned. The filing identifies Summit Partners, L.P. as manager of the funds holding the shares and names three investment committee members who may be deemed to have voting and dispositive authority, while disclaiming beneficial ownership except for any pecuniary interest.
Luciano Fernandez Gomez, a director of Klaviyo, Inc. (KVYO), reported transactions on 08/15/2025 involving the conversion and settlement of equity tied to RSU vesting. Seven thousand (7,000) shares of Series B Common Stock converted into Series A Common Stock and were recorded as acquired; concurrently the issuer withheld 7,000 shares of Series A Common Stock to satisfy tax withholding obligations at a price of $31.43 per share. After these reported transactions the filing shows beneficial ownership positions that include 26,788 shares of Series A Common Stock (comprised of 20,968 shares and 5,820 unvested RSUs) and a separate derivative table showing 56,000 underlying Series A shares equivalent from outstanding derivatives/unvested awards. The filing was signed by an attorney-in-fact on 08/19/2025.
Amanda Whalen, Chief Financial Officer of Klaviyo, Inc. (KVYO), reported multiple equity transactions on 08/15/2025. The filing shows 29,513 shares of Series B common stock converted into Series A common stock in connection with tax withholding for vested RSUs. The issuer withheld 46,829 Series A shares to satisfy tax withholding and the reporting person sold 15,000 Series A shares pursuant to a Rule 10b5-1 trading plan adopted August 16, 2024. The sale prices reported range from $30.92 to $31.53 with weighted averages shown as $31.43 and $31.32. Following these transactions, the filing reports 485,515 shares of Series A common stock beneficially owned and 419,680 derivative shares underlying options or awards.
Klaviyo insider reported routine transactions by Galvin Carmel, Chief People Officer. On 08/15/2025 the company withheld 24,817 shares of Series A common stock to satisfy tax withholding for RSU vesting at a price of $31.43 per share. On 08/18/2025 the reporting person sold 11,155 shares under a Rule 10b5-1 plan (adopted 11/26/2024) at a weighted average price of $31.67 per share.
Following these transactions the reporting person beneficially owns 675,833 shares directly, comprised of 86,858 vested shares and 588,975 unvested RSUs that convert to one share each upon vesting. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Stephen Eric Rowland, President of Klaviyo, Inc. (KVYO), reported multiple equity transactions in mid-August 2025. On 08/15/2025 and 08/18/2025 he received 22,855 and 28,457 shares respectively through conversion of Series B common stock into Series A common stock related to RSU settlements and a conversion provision. The filing shows the issuer withheld 34,326 shares on 08/15/2025 to satisfy tax withholding and Rowland sold 7,105 shares on 08/18/2025 for a weighted average price of about $31.46 under a Rule 10b5-1 trading plan adopted November 22, 2024. After these transactions the filing reports 445,726 shares beneficially owned, consisting of vested shares and unvested RSUs.
Klaviyo Chief Legal Officer Edmond Landon reported multiple transactions in August 2025 affecting his beneficial ownership of Klaviyo (KVYO) stock. On 08/15/2025 and 08/18/2025 Mr. Landon received 22,500 shares of Series B Common Stock that converted into Series A Common Stock in connection with RSU vesting and tax withholding; the issuer also withheld 24,695 Series A shares to satisfy taxes. He sold 9,965 shares on 08/18/2025 under a Rule 10b5-1 plan at a weighted average price of $31.46 (sales ranged $31.20–$31.76). After these transactions he beneficially owned 392,584 shares (including 113,798 vested Series A shares and 278,786 unvested RSUs). The Form 4 discloses conversion mechanics, withholding for taxes, and that the 10b5-1 plan was adopted on 08/16/2024.
Klaviyo, Inc. (KVYO) reported a Form 144 notice indicating an intended sale of 7,105 common shares with an aggregate market value of $223,310.15, representing part of the issuer's 116,897,730 outstanding shares. The shares are scheduled for sale approximately on 08/18/2025 on the NYSE. The filer acquired the shares as restricted stock units on 08/15/2025 and lists payment as N/A. The filing also discloses two prior 10b5-1 sales by Stephen Rowland of 7,079 shares on 07/15/2025 (gross proceeds $223,446.27) and 06/16/2025 (gross proceeds $244,619.43).
Klaviyo, Inc. (KVYO) Form 144 notice reports a proposed sale of 9,965 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $313,199.95. The filing lists 116,897,730 shares outstanding and an approximate sale date of 08/18/2025. The shares were acquired as Restricted Stock Units from the issuer on 08/15/2025 and payment/settlement is shown as 08/15/2025. The form indicates no securities sold in the past three months and contains the standard representation that the selling person does not possess undisclosed material adverse information. Several identifying fields (filer name/CIK and issuer contact details) are not populated in the provided content.